Tilray Brands (TLRY) Cash from Operations (2017 - 2026)
Tilray Brands' (TLRY) quarterly Cash from Operations came in at 37324000.0 in Q2 2026, down 191.43% YoY from 40820535.27 in Q2 2025, and down 70.1% on a QoQ basis from 21942000.0 in Q1 2026.
Tilray Brands (TLRY) Cash from Operations (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 10 years of Cash from Operations data on file, last reported at 37324000.0 in Q2 2026.
- Quarterly Cash from Operations fell 191.43% year-over-year to 37324000.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was 69144000.0 (up 26.91% YoY) and the FY2026 annual result came in at 69144000.0, up 26.91% from the prior year.
- Cash from Operations slipped to 37324000.0 in Q2 2026, from 21942000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 43598000.0 in Q2 2023 to a low of 46390000.0 in Q1 2022.
- A 5-year average of 14092000.0 and a median of 17237000.0 in 2023 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations tumbled 348.81% — and 2023, when it jumped 312.42%.
- Tracing TLRY's Cash from Operations over 5 years: stood at 29209000.0 in 2022, then plunged by 204.11% to 30409000.0 in 2023, then tumbled by 33.92% to 40724000.0 in 2024, then surged by 79.04% to 8537000.0 in 2025, then plunged by 337.2% to 37324000.0 in 2026.
- The last three Cash from Operations figures came in at 37324000.0 (Q2 2026), 21942000.0 (Q1 2026), and 8537000.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Tilray Brands | 523.93 Mn | 289.30 Mn | 90.52 Mn | -37.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -37.32 Mn |
| May 31, 2026 | -37.32 Mn |
| Feb 28, 2026 | -21.94 Mn |
| Feb 28, 2026 | -21.94 Mn |
| Nov 30, 2025 | -8.54 Mn |
| Nov 30, 2025 | -8.54 Mn |
| Aug 31, 2025 | -1.34 Mn |
| Aug 31, 2025 | -1.34 Mn |
| May 31, 2025 | -12.81 Mn |
| May 31, 2025 | -12.81 Mn |
| Feb 28, 2025 | -5.76 Mn |
| Feb 28, 2025 | -5.76 Mn |
| Nov 30, 2024 | -40.72 Mn |
| Nov 30, 2024 | -40.72 Mn |
| Aug 31, 2024 | -35.31 Mn |
| Aug 31, 2024 | -35.31 Mn |
| May 31, 2024 | 30.71 Mn |
| May 31, 2024 | 30.71 Mn |
| Feb 29, 2024 | -15.36 Mn |
| Feb 29, 2024 | -15.36 Mn |